Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has proven effective for weight loss in clinical trials, with patients losing up to 15% of body weight over 68 weeks. PlexusDx provides access to compounded semaglutide injections from licensed 503A pharmacies across all 50 states, with pricing that stays flat regardless of your dose level. Understanding how this medication works and what to expect can help you make an informed decision about your weight loss journey.

How Semaglutide Works for Weight Loss

Semaglutide activates GLP-1 receptors in the brain's appetite control centers, signaling fullness and reducing hunger between meals. This mechanism also slows gastric emptying—the rate at which food leaves your stomach—which extends feelings of satisfaction after eating. The medication simultaneously improves how your body processes blood sugar, reducing cravings for high-calorie foods and stabilizing energy levels throughout the day.

The drug mimics glucagon-like peptide-1, a natural hormone your body produces when you eat protein or healthy fats. By amplifying this signal, semaglutide helps reset your relationship with food, making smaller portions feel adequate and reducing the drive to snack or eat emotionally. Clinical data shows these effects begin within days of starting treatment, though maximum appetite suppression typically occurs after 4-8 weeks of consistent dosing.

Expected Weight Loss Results and Timeline

Most patients experience measurable weight loss within 2-4 weeks of beginning semaglutide therapy, with average losses of 1-2 pounds per week during the first month. Longer-term studies demonstrate that patients can achieve 10-15% total body weight reduction by week 16, and some reach 18-22% reductions when combined with lifestyle modifications. Individual results vary based on baseline metabolism, dietary adherence, physical activity, and genetic factors that influence how your body responds to GLP-1 signaling.

The weight loss trajectory follows a typical pattern: rapid initial losses during dose escalation, followed by steady progress as your body adjusts, and then plateau periods where your weight stabilizes before dropping again. Consistency matters more than speed—patients who maintain their dosing schedule and combine medication with balanced nutrition and movement see the most sustained results. PlexusDx's Precision Peptide Genetic Test identifies your individual peptide-pathway variations, helping predict your likely response trajectory and optimize dosing for your unique biology.

Side Effects and Safety Considerations

Common side effects during the first 1-2 weeks include mild nausea, reduced appetite (the intended effect), and occasional constipation or stomach discomfort as your digestive system adapts. These effects are typically temporary and diminish as your body becomes accustomed to the medication, though some patients continue to experience mild nausea if doses escalate too rapidly. Serious side effects are rare when prescribed through licensed medical channels, but include pancreatitis symptoms (severe abdominal pain), signs of allergic reaction, or rapid heart rate—all requiring immediate medical attention.

Semaglutide must be used cautiously in patients with a personal or family history of medullary thyroid cancer, and it is not appropriate for pregnant individuals. Dehydration can occur if you reduce food intake without increasing water consumption, so maintaining hydration is essential. PlexusDx connects you with healthcare providers who monitor your treatment progress, screen for contraindications, and adjust your protocol if side effects become problematic, ensuring safe and sustainable results.

Personalized Dosing and PlexusDx Access

PlexusDx offers compounded semaglutide injections starting at $149 per month, with flat pricing across all dose levels—meaning your cost remains the same whether you use a 0.5mg or 2.4mg weekly dose. Treatment begins with a low starting dose to minimize side effects, then increases gradually based on your tolerance and weight loss progress, typically advancing every 4 weeks until reaching your therapeutic dose. No insurance is required, no membership fees apply, and all injections come from licensed 503A compounding pharmacies verified to meet strict pharmaceutical standards.

The Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 pathways and 49 peptides to reveal genetic variants influencing your GLP-1 receptor sensitivity, appetite regulation, and metabolic rate. Key variants like GLP1R rs6923761 and GIPR rs1800437 help predict your likely response speed and optimal dosing strategy, while MC4R rs17782313 and FTO rs9939609 inform your individual nutrition and exercise recommendations. This personalization transforms semaglutide from a one-size-fits-all approach into a precision therapy tailored to your genetic profile, increasing the likelihood of success and minimizing trial-and-error adjustments.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I see weight loss results with semaglutide?

Most PlexusDx patients report noticeable appetite reduction within 3-5 days and measurable weight loss (1-2 pounds) within 2-4 weeks of starting treatment. Full results take 12-16 weeks of consistent dosing combined with balanced nutrition and movement, with some individuals continuing to lose weight for up to 6 months as their dose stabilizes.

Is compounded semaglutide as effective as brand-name Wegovy?

Compounded semaglutide from licensed 503A pharmacies contains the same active ingredient and dosing options as brand medications, with equivalent clinical effectiveness when produced under strict pharmaceutical standards. PlexusDx's compounded semaglutide eliminates middleman markups, delivering the same results at a fraction of the cost—starting at $149/month with no insurance required.

Can I use semaglutide if I'm not diabetic?

Yes, semaglutide is safe and effective for weight loss in non-diabetic individuals, and PlexusDx specializes in providing it for weight management without requiring a diabetes diagnosis. The medication works identically on appetite and metabolism regardless of your blood sugar status, and PlexusDx healthcare providers screen for any contraindications during your initial consultation.

What happens if I stop taking semaglutide?

Weight typically returns gradually over several months after discontinuing semaglutide, as your appetite-regulating hormones readjust to pre-medication levels. Many patients maintain 50-70% of their lost weight long-term if they sustain the lifestyle habits (nutrition, exercise, sleep) developed during treatment, making semaglutide a launching point for lasting change rather than a temporary fix.

How does PlexusDx's genetic test personalize my semaglutide treatment?

The Precision Peptide Genetic Test identifies your unique variants in GLP-1 receptor sensitivity, appetite-control pathways, and metabolic genes, predicting whether you'll respond quickly or need longer to reach therapeutic dose. This insight allows PlexusDx to optimize your dosing schedule and pair your medication with tailored nutrition and exercise strategies, dramatically increasing your success rate compared to standard one-dose-fits-all approaches.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves